Market Cap

ReproCELL, Inc. Market Capitalization:

¥15.34 Billion

JPY as of Jan. 1, 2026

US$97.9 Million

business ReproCELL, Inc. Company Profile

ReproCELL, Inc. Main Stock Listing

JPX: 4978

Market Capitalization History of ReproCELL, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of ReproCELL, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥15.34 B 50.73%
Jan. 1, 2025 ¥10.18 B -30.88%
Jan. 1, 2024 ¥14.72 B -36.95%
Jan. 1, 2023 ¥23.35 B 29.22%
Jan. 1, 2022 ¥18.07 B -46.19%
Jan. 1, 2021 ¥33.59 B 19.35%
Jan. 1, 2020 ¥28.14 B 59.35%
Jan. 1, 2019 ¥17.66 B -40.72%
Jan. 1, 2018 ¥29.79 B -13.64%
Jan. 1, 2017 ¥34.49 B 14.52%
Jan. 1, 2016 ¥30.12 B -50.47%
Jan. 1, 2015 ¥60.82 B -47.09%
Jan. 1, 2014 ¥114.95 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

ReproCELL, Inc. Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

ReproCELL, Inc. has the following listings and related stock indices.


Stock: JPX: 4978

Stock: FSX: 6RC

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.